Anti-diabetic effects of resveratrol
- PMID: 21261639
- DOI: 10.1111/j.1749-6632.2010.05844.x
Anti-diabetic effects of resveratrol
Abstract
Diabetes mellitus is a complex metabolic disease affecting about 5% of people all over the world. Data from the literature indicate that resveratrol is a compound exerting numerous beneficial effects in organisms. Rodent studies, for example, have demonstrated that resveratrol decreases blood glucose in animals with hyperglycemia. This effect seems to predominantly result from increased intracellular transport of glucose. Resveratrol was also demonstrated to induce effects that may contribute to the protection of β cells in diabetes. In experiments on pancreatic islets, the ability of resveratrol to reduce insulin secretion was demonstrated; this effect was confirmed in animals with hyperinsulinemia, in which resveratrol decreased blood insulin levels. Moreover, inhibition of cytokine action and attenuation of the oxidative damage of the pancreatic tissue by resveratrol were recently shown. Studies of animals with insulin resistance indicate that resveratrol may also improve insulin action. The mechanism through which resveratrol improves insulin action is complex and involves reduced adiposity, changes in gene expression, and changes in the activities of some enzymes. These data indicate that resveratrol may be useful in preventing and treating diabetes.
© 2011 New York Academy of Sciences.
Similar articles
-
Resveratrol and diabetes: from animal to human studies.Biochim Biophys Acta. 2015 Jun;1852(6):1145-54. doi: 10.1016/j.bbadis.2014.10.013. Epub 2014 Oct 27. Biochim Biophys Acta. 2015. PMID: 25445538 Review.
-
Protection of pancreatic beta-cells: is it feasible?Nutr Metab Cardiovasc Dis. 2008 Jan;18(1):74-83. doi: 10.1016/j.numecd.2007.05.004. Nutr Metab Cardiovasc Dis. 2008. PMID: 18096375 Review.
-
Ameliorative potential of resveratrol on proinflammatory cytokines, hyperglycemia mediated oxidative stress, and pancreatic beta-cell dysfunction in streptozotocin-nicotinamide-induced diabetic rats.J Cell Physiol. 2010 Aug;224(2):423-32. doi: 10.1002/jcp.22138. J Cell Physiol. 2010. PMID: 20333650
-
Resveratrol and diabetes: A critical review of clinical studies.Biomed Pharmacother. 2017 Nov;95:230-234. doi: 10.1016/j.biopha.2017.08.070. Epub 2017 Sep 12. Biomed Pharmacother. 2017. PMID: 28843911 Review.
-
Resveratrol, obesity and diabetes.Eur J Pharmacol. 2010 Jun 10;635(1-3):1-8. doi: 10.1016/j.ejphar.2010.02.054. Epub 2010 Mar 19. Eur J Pharmacol. 2010. PMID: 20303945 Review.
Cited by
-
SEAP activity serves for demonstrating ER stress induction by glucolipotoxicity as well as testing ER stress inhibitory potential of therapeutic agents.Mol Cell Biochem. 2015 Jun;404(1-2):271-9. doi: 10.1007/s11010-015-2387-1. Epub 2015 Mar 17. Mol Cell Biochem. 2015. PMID: 25776571
-
Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease.World J Hepatol. 2014 Apr 27;6(4):188-98. doi: 10.4254/wjh.v6.i4.188. World J Hepatol. 2014. PMID: 24799987 Free PMC article. Review.
-
The Fluid Aspect of the Mediterranean Diet in the Prevention and Management of Cardiovascular Disease and Diabetes: The Role of Polyphenol Content in Moderate Consumption of Wine and Olive Oil.Nutrients. 2019 Nov 19;11(11):2833. doi: 10.3390/nu11112833. Nutrients. 2019. PMID: 31752333 Free PMC article. Review.
-
Functional Foods and Lifestyle Approaches for Diabetes Prevention and Management.Nutrients. 2017 Dec 1;9(12):1310. doi: 10.3390/nu9121310. Nutrients. 2017. PMID: 29194424 Free PMC article. Review.
-
Differential gene expression in liver tissues of streptozotocin-induced diabetic rats in response to resveratrol treatment.PLoS One. 2015 Apr 23;10(4):e0124968. doi: 10.1371/journal.pone.0124968. eCollection 2015. PLoS One. 2015. PMID: 25905778 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
